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Charcot-Marie-Tooth disease type 1A (CMT1A) is associated with duplication of chromosome 17p11.2-p12, 
whereas hereditary neuropathy with liability to pressure palsies (HNPP), which is an autosomal dominant neuropathy 
showing characteristics of recurrent pressure palsies, is associated with 17p11.2-p12 deletion. An altered gene 
dosage of PMP22 is believed to the main cause underlying the CMT1A and HNPP phenotypes. Although CMT1A and 
HNPP are associated with the same locus, there has been no report of these two mutations within a single family. 
We report a rare family harboring CMT1A duplication and HNPP deletion.
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Charcot-Marie-Tooth (CMT) disease type 1A (CMT1A), 
the most common type of CMT neuropathy, is asso-
ciated with duplication of chromosome 17p11.2-p12, 
whereas hereditary neuropathy with liability to pressure 
palsies (HNPP), which is an autosomal dominant neuro-
pathy showing characteristics of recurrent pressure palsies, 
is associated with 17p11.2-p12 deletion. The proximal 
and distal CMT1A-REP repeats on 17p11.2-p12 are in-
volved in unequal crossover resulting in CMT1A 
duplication and HNPP deletion.
2 A gene dosage effect of 
peripheral myelin protein 22 (PMP22) is considered to 
be the chief mechanism underlying the development of 
CMT1A and HNPP.
3 The genetic mechanism causing 
the CMT1A duplication is unequal nonsister chromatid 
exchange during spermatogenesis.
4 Therefore, it has been 
reported that the prevalence of de novo duplications in 
CMT1A is much higher for those of paternal origin than 
for those of maternal origin.
5
Even though CMT1A and HNPP are associated with 
the same locus, there have been no reports of the occu-
rrence of these two mutations in a single family. Here, 
we report a de novo CMT1A patient of paternal origin 
in a family with HNPP harboring a deletion.
CASE REPORT
Patient 1 (proband, III-1 Fig. 1) was an 11-year-old girl 
with a normal birth. She had experienced gait abnorma-
lities from infancy. At the age of 2 years, she was 
observed to walk ploddingly with frequent stumbling. At 
5 years, a wasting of bilateral leg muscles was evident, 
and she wore a foot brace. The motor weakness and 
wasting were more severe in the lower distal extremities Journal of Clinical Neurology: Vol. 3, No. 2, 2007
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Table 1. Nerve-conduction data of patient 1 (with PMP22 duplication) and patient 2 (with PMP22 deletion)
Patient 1 (III-1) Patient 2 (II-4)
Latency Amplitude NCV  　 Latency Amplitude NCV 
Motor NCS
  Median nerve
     APB, wrist 6.6 ms 7.5 mV 6.1 ms 14.4 mV
     Wrist, elbow 6.2 mV 15.4 m/s 13.7 mV 52.3 m/s
     Elbow, axilla 6.1 mV 19.2 m/s 13.4 mV 66.6 m/s
  Ulnar nerve
     ADM, wrist 5.5 ms 7.8 mV 2.6 ms 19.9 mV
     Wrist, below elbow 6.6 mV 13.2 m/s 18.3 mV 50.5 m/s
     Wrist, above elbow 5.4 mV 14.5 m/s 17.8 mV 68.2 m/s
     Elbow, axilla 3.3 mV 14.8 m/s 17.0 mV 55.9 m/s
  Peroneal nerve
     EDB, ankle 10.4 ms 0.8 mV 5.5 ms  3.7 mV
     Ankle, fibular head 0.2 mV 11.3 m/s    3.6 mV 44.2 m/s
  Tibial nerve
     AH, ankle 14.5 ms 2.4 mV 4.2 ms 16.9 mV
     Ankle, knee 0.4 mV 11.9 m/s  8.0 mV 44.9 m/s
Sensory NCS
  Median nerve
     Finger, wrist 3.1 μV 11.2 m/s  7.6 μV2 2 . 1  m / s
     Wrist, elbow 8.7 μV 20.1 m/s 28.3 μV4 7 . 3  m / s
  Ulnar nerve
     Finger, wrist NR NR 10.7 μV2 7 . 6  m / s
     Wrist, elbow 6.4 μV 15.5 m/s 23.0 μV4 4 . 1  m / s
  Sural nerve 　 NR NR 　　  8.2 μV2 9 . 0  m / s
NCS; nerve-conduction study, APB; abductor pollicis brevis, ADM; abductor digiti minimi, EDB; extensor digitorum brevis, 
AH; abductor hallucis, NR; not recordable.
than in the upper extremities. Muscular stretch reflexes 
were absent, and vibratory sense and pain appreciation 
were impaired distally in both upper and lower limbs.
Patient 2 (proband’s mother, II-4) was a 45-year-old 
woman born after a normal delivery. All early develop-
mental milestones were achieved. At the age of 27 
years, she experienced weakness of both upper extre-
mities that lasted for 3 months after giving birth. She 
experienced sensory impairment of the right upper 
extremity after working hard. Also, her mother (I-2) and 
two sisters (II-1 and -2) experienced similar recurrent 
episodes of weakness and sensory impairments after the 
application of minor pressure. A neurological examina-
tion did not reveal any muscular atrophy. Muscular 
stretch reflexes were present and all sensory modalities 
were intact.
Nerve conduction was investigated in this family 
(Table 1). The proband showed markedly reduced motor 
nerve conduction velocities (NCVs) with prolonged 
distal motor latencies. However, patient 2 exhibited focal 
neuropathy with common entrapment sites. The median 
motor NCVs of the proband and her mother were 15.4 
and 52.3 m/s, respectively (normal value in our labora-
tory  ≥ 50.5 m/s). Stimulation at the wrist, elbow, and 
above the elbow evoked motor compound muscle action 
potentials with normal amplitudes, and no conduction 
block was observed in either patient (Fig. 2). 
Mutational analysis of the family was performed 
(Fig. 1). Six microsatellite markers within 17p11.2-p12 
(D17S921, D1S9B, D17S9A, D17S918, D17S4A, and 
D17S2230) were genotyped to determine the presence of 
duplication or deletion. We identified a 17p11.2-p12 Lee JH, et al. A Family Harboring CMT1A Duplication and HNPP Deletion
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Figure 1. Pedigree of the family with peripheral neuropathy. 
The proband (III-1) was identified with a de novo CMT1A 
duplication of paternal origin, whereas her mother (II-4) 
carried an HNPP deletion (open symbols: unaffected; black 
symbols: HNPP; gray symbol: CMT1A).
Figure 2. Conduction in the median nerve showing the uniform shape and amplitudes of the compound muscle action potential 
for stimulation at the wrist, elbow, and above the elbow. The different gene dosages of the same region (1.5 for CMT1A 
and 0.5 for HNPP compared with control) resulted in different electrophysiological features in the family. (A) Patient 1 (III-1) 
with 17p11.2-p12 duplication, and (B) patient 2 (II-4) with 17p11.2-p12 deletion.
deletion in patient 2 (II-4), and diagnosed her as HNPP. 
However, the proband (III-1) was determined as having 
a de novo duplication of paternal origin. The duplication 
contained both paternal haplotypes, indicating that the 
de novo mutation was caused by an unequal nonsister 
chromatid crossover at paternal meiosis. No other cau-
sative mutation in PMP22,  MPZ,  GJB1,  EGR2,  NEFL, 
PRX, or MFN2 was identified in this family.
DISCUSSION
CMT disease and HNPP are genetically and pheno-
typically heterogeneous peripheral neuropathies.
1  CMT1A 
duplication and HNPP deletion are due to a reciprocal 
unequal crossover event between flanking CMT1A-REP 
repeats and the PMP22 gene locates within the 17p11.2- 
p12 region.
2 There are several lines of evidence that 
alterations in the gene dosage of PMP22 are the main 
cause of the CMT1A phenotype.
3 Namely, patients ca-
rrying one extra copy of PMP22 develop CMT1A, while 
patients with HNPP deletion have only one copy of 
PMP22.
3 This is reflected in reduced mRNA and protein Journal of Clinical Neurology: Vol. 3, No. 2, 2007
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levels in sural nerve biopsy samples from HNPP 
patients.
6 Myelin plays an important role in the saltatory 
impulse transmission along neuronal extensions and 
communication between neurons, and the level of 
PMP22 expression must be maintained within the cri-
tical range for proper peripheral nerve function.
7 
It is believed that CMT1A and HNPP are both de-
myelinating neuropathies, but their clinical, electrophysio-
logical, and histopathological features are quite distinct.
6 
CMT1A patients with duplication develop slowly pro-
gressive sensorimotor length-dependent neuropathies asso-
ciated with uniformly slow NCVs, and HNPP is charac-
terized by recurrent episodes of focal entrapment neuro-
pathies occurring as a result of trivial trauma or pressure.
8 
However, most HNPP patients exhibit conduction slowing 
only at sites of mechanical compression, but mild overlap 
of clinical features with CMT may lead patients with 
HNPP to be misdiagnosed as having CMT1A.
6 More-
over, all heterozygous patients with a PMP22 point 
mutation (T118M) had clinical and electrophysiological 
features of a neuropathy similar to HNPP by a partial 
loss of PMP22 function.
7
CMT is frequently classified into type 1 (the demyeli-
nating form; CMT1) and type 2 (the axonal form; 
CMT2).
1 The primary defect in CMT2 patients is 
neuronal, with them exhibiting slightly reduced (>38 or 
even normal NCVs.
9 Recent studies have defined inter-
mediate-type CMT, which has electrophysiological and 
pathological features of both CMT1 and CMT2.
10  Before 
performing the mutation analysis, we considered this 
family to be of intermediate-type CMT, because the 
median NCV of the proband (III-1; Fig. 2-A) was 
markedly reduced, whereas that of her mother (II-4; Fig. 
2-B) was not reduced. However, it was subsequently 
revealed that the heterogeneous phenotypes were due to 
different genetic defects: a duplication of 17p11.2-p12 
was detected in the proband (III-1), whereas a deletion 
of the same region was found in her mother (II-4). 
Although the occurrence of CMT1A duplication and 
HNPP deletion in this family might be purely coinci-
dental, the presence of both of them in the same inherited 
neuropathy family might have resulted as misdiagnosis 
of intermediate-type CMT.
In addition, patient 2 (II-1) had a de novo CMT1A 
duplication, and this was attributed to unequal nonsister 
chromatid exchange during spermatogenesis.
4 The preva-
lence of de novo duplications in CMT1A is much higher 
for those of paternal origin than for those of maternal 
origin, which may be due to the recombination fractions 
for the region being larger in females.
5
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